APA (7th ed.) Citation

Hannani, D., Vétizou, M., Enot, D., Rusakiewicz, S., Chaput, N., Klatzmann, D., . . . Zitvogel, L. (2015). Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25: Corrigendum. Cell research, 25(3), . https://doi.org/10.1038/cr.2015.28

Chicago Style (17th ed.) Citation

Hannani, Dalil, et al. "Anticancer Immunotherapy by CTLA-4 Blockade: Obligatory Contribution of IL-2 Receptors and Negative Prognostic Impact of Soluble CD25: Corrigendum." Cell Research 25, no. 3 (2015). https://doi.org/10.1038/cr.2015.28.

MLA (9th ed.) Citation

Hannani, Dalil, et al. "Anticancer Immunotherapy by CTLA-4 Blockade: Obligatory Contribution of IL-2 Receptors and Negative Prognostic Impact of Soluble CD25: Corrigendum." Cell Research, vol. 25, no. 3, 2015, https://doi.org/10.1038/cr.2015.28.